HTI
RPRX icon

Hikari Tsushin Inc’s Royalty Pharma RPRX Stock Holding History

Hikari Tsushin Inc’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Hold
2,220
– – 0.01% 72
2026
Q1 		$106K Hold
2,220
– – 0.01% 72
2025
Q4 		$85.8K Hold
2,220
– – 0.01% 76
2025
Q3 		$78.3K Hold
2,220
– – 0.01% 73
2025
Q2 		$80K Hold
2,220
– – 0.01% 74
2025
Q1 		$69.1K Hold
2,220
– – ﹤0.01% 69
2024
Q4 		$56.6K Hold
2,220
– – ﹤0.01% 70
2024
Q3 		$62.8K Hold
2,220
– – ﹤0.01% 69
2024
Q2 		$58.5K Hold
2,220
– – ﹤0.01% 68
2024
Q1 		$67.4K Hold
2,220
– – 0.01% 64
2023
Q4 		$62.4K Hold
2,220
– – 0.01% 61
2023
Q3 		$60.3K Hold
2,220
– – 0.01% 57
2023
Q2 		$68.2K Hold
2,220
– – 0.01% 55
2023
Q1 		$80K Hold
2,220
– – 0.01% 55
2022
Q4 		$87.7K Buy
2,220
+1,830
+469% +$76.4K 0.01% 55
2022
Q3 		$16K Hold
390
– – ﹤0.01% 52
2022
Q2 		$16K Buy
+390
New +$16K ﹤0.01% 54

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Tsushin Inc's RPRX Position: Q2 2026 in Review

Hikari Tsushin Inc held its Royalty Pharma (RPRX) position steady in Q2 2026 at 2,220 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #72.

Hikari Tsushin Inc first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Hikari Tsushin Inc held 2,220 shares of Royalty Pharma worth $124K as of Q2 2026.
  • Hikari Tsushin Inc left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up 0.01% of Hikari Tsushin Inc's portfolio in Q2 2026, its #72 holding.
  • Hikari Tsushin Inc first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Hikari Tsushin Inc's 13F filing for Q2 2026, filed 12 Aug 2026.